Raymond James Financial Services Advisors »

Fusion Pharmaceuticals shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Fusion Pharmaceuticals (FUSN) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Fusion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fusion Pharmaceuticals held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fusion Pharmaceuticals by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $769k 36k 21.32
2023-12-31 $299k 31k 9.61

More positions owned by Raymond James Financial Services Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Vanguard Index Fds Value Etf (VTV)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Raymond James Financial Services Advisors

Top funds holding Fusion Pharmaceuticals

Federated Investors
Avidity Partners Management
Deerfield Management Company
OrbiMed Advisors
Perceptive Advisors
Tpg Gp A
Sphera Funds Management
Artal Group
William Blair $ Company
Wellington Management Company
Eagle Health Investments
Millennium Management
Ikarian Capital
Marshall Wace
Fred Alger Management

View all funds holding Fusion Pharmaceuticals